EndoCyclic New Drug application approved by US FDA for endometriosis treatment
March 24, 2026Research and Development EndoCyclic Therapeutics, FDA, endometriosis
EndoCyclic Therapeutics’ Investigational New Drug (IND) application for its lead programme, ENDO-205, has been approved by the US FDA. With …
Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer
March 23, 2026Mestag Therapeutics
Mestag has appointed Lindsey Rolfe as Chief Medical Officer (CMO) and Pascal Merchiers as Chief Development Officer (CDO). Bringing over …
Outrun Therapeutics announces its lead programme for HPV positive cancer
March 23, 2026Research and Development HPV, Oncology, Outrun Therapeutics
Outrun Therapeutics has selected an E6AP inhibitor strategy as its lead programme for treating HPV positive head and neck cancer. …
IsomAb appoints Philip Brainin as CEO
March 19, 2026IsomAb
IsomAb has appointed Dr Philip Brainin as CEO and member of the Board of Directors. In this new role, Dr …
Naobios partners with SGS to manufacture RSV challenge agent
March 19, 2026Manufacturing and Production Naobios, RSV, SGS
Contract Development and Manufacturing Organisation (CDMO) Naobios has partnered with SGS, a testing, inspection and certification company, to manufacture a …
Qlaris Bio appoints Fred Guerard as President and CEO
March 18, 2026Qlaris Bio
Qlaris Bio, a clinical-stage biotechnology company, has appointed Fred Guerard as president and CEO. Guerard will also join the Board …
Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC
March 18, 2026Research and Development NHS, University of Huddersfield, West Yorkshire
Dr Zubir Ahmed MP, the Under-Secretary of State for Health Innovation and Safety, has visited the recently opened Emily Siddon …
AEON Biopharma appoints John Bencich as CFO
March 17, 2026AEON Biopharma
AEON Biopharma, a biopharmaceutical company, has appointed John Bencich as Chief Financial Officer (CFO). Bringing more than 25 years of …
Canada awards CSL Seqirus with influenza pandemic vaccine contract
March 17, 2026Manufacturing and Production CSL Seqirus, Canada, Vaccine
CSL Seqirus has been awarded a contract committing it to manufacturing and delivering influenza vaccines to support the Public Health …
Helus Pharma appoints Jill Conwell as Chief People Officer
March 16, 2026Helus Pharma
Helus Pharma, a clinical stage pharmaceutical company focussed on developing novel serotonergic agonists (NSAs), has appointed Jill Conwell as Chief …
Coriolis Pharma opens new US headquarter and laboratory
March 16, 2026Manufacturing and Production Coriolis Pharma, US, development
Coriolis Pharma has opened a new US headquarter and laboratory at the Alexandria Center for Advanced Technologies (ACAT) in North …
Thermo Fisher opens new distribution centre in Ireland
March 12, 2026Warehousing & distribution Ireland, Thermo Fisher Scientific, distribution
Thermo Fisher Scientific has announced the opening of a new 70,000sqft distribution centre in Bracetown, County Meath, Ireland, expanding its …
Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer
March 12, 2026Altimetrik
Altimetrik, an AI-first data and digital-engineering company, has appointed Dhirendra Nath as Chief Human Resources Officer (CHRO). This appointment comes …
Kindeva appoints Mike Cowhig as Chief Legal Officer
March 11, 2026Kindeva
Kindeva, a global drug delivery contract and development organisation (CDMO), has appointed Mike Cowhig as Chief Legal Officer. Bringing over …
DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study
March 11, 2026Research and Development DiaMedica, Health Canada, preeclampsia
DiaMedica Therapeutics has received a No Objection Letter (NOL) from Health Canada, giving the company regulatory clearance to start its …
Abselion establishes a US subsidiary in MassachusettsÂ
March 10, 2026Research and Development Abselion, The Engine, US
Abselion has established a US subsidiary at The Engine in Cambridge, Massachusetts in the US. The company aims to strengthen …
Latigo Biotherapeutics appoints Neha Krishnamohan as CFO and CBO
March 10, 2026Latigo Biotherapeutics
Latigo Biotherapeutics, a clinical-stage biopharmaceutical company developing non-opioid pain medicines, announced the appointment of Neha Krishnamohan as Chief Financial Officer …
Cellbox appoints Bernd Muehlenweg as new CBO and CFO
March 9, 2026Cellbox Solutions
Cellbox Solutions has appointed Bernd Muehlenweg as Chief Business Officer (CBO) and Chief Financial Officer (CFO). Bernd brings over 20 …
Antiverse receive investment from IIC and Development Bank of Wales
March 9, 2026Research and Development Antiverse, Wales, funding
As part of its $9.3m Series A funding round, Antiverse has received a joint equity investment by Innovation Investment Capital …
Five Facts about the menopause
March 6, 2026Medical Communications Five Facts, HRT, menopause, perimenopause
1 Menopause is when periods stop due to decreasing hormone levels. It generally begins between the ages of 45 and …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
